Featured Research

from universities, journals, and other organizations

Study Demonstrates That Lung Cancer Susceptibility Runs In Families

Date:
April 3, 2006
Source:
University of Texas M. D. Anderson Cancer Center
Summary:
Studying thousands of people, researchers at The University of Texas M. D. Anderson Cancer Center have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.

Washington, D.C. - Studying thousands of people, researchers at The University of Texas M. D. Anderson Cancer Center have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.

Researchers say their study, one of the largest ever done and the only one to include both men and women, strongly suggests that these lung cancer patients and their affected relatives share an inherited genetic susceptibility to cancer development.

"This study demonstrates the importance of familial factors in the general development of cancer," says the study's first author, Olga Gorlova, Ph.D., assistant professor in the Department of Epidemiology. "These susceptibility factors can be environmental, but are more likely to be influenced by genetic factors, because genes control pathways common to a number of cancers."

Such marked cancer susceptibility also likely explains why patients in this study, who never smoked but might have been exposed to secondhand smoke, developed lung cancer in the first place, she says. Gorlova will present the study at the annual meeting of the American Association for Cancer Research (AACR). She will discuss the findings in a press briefing on Tuesday, April 4, 2006 at 11 a.m.

The research team, headed by Margaret Spitz, M.D., professor and chair of the Department of Epidemiology, looked at whether 2,465 first-degree relatives of 316 lung cancer patients who never smoked developed cancer. They also established a matched comparison group of 2,442 first-degree relatives of 318 "controls" - individuals who also never smoked but did not have lung cancer. (An individual's first-degree relatives include his/her parents, children and siblings - people who share one-half of that individual's genes.)

The median age of both cases (patients) and controls was about 61 years, and the median number of first-degree relatives was eight for both groups.

The researchers compared cancer incidence between the two groups adjusting their findings to eliminate the influence of age, gender, ethnicity and smoking status.

They discovered:

  • First-degree relatives of cases had a 25 percent increased risk of developing any type of cancer, compared to controls. Cancers diagnosed in the relatives include melanoma, colorectal, head and neck cancer, lung, prostate and breast cancers.
  • Case relatives were about 10 years younger when they were diagnosed with cancer, compared to control relatives.
  • A 44 percent excess risk of young onset cancers - those diagnosed before age 50 - among case relatives.
  • More than a six-fold risk of developing young onset lung cancer in the case families compared to control families.
  • Relatives of case patients had a 68 percent increased risk of developing lung cancer.
  • Mothers of case patients had more than a two-fold risk of developing breast cancer.

"It has long been observed that cancer seems to occur in some families more than in others, and with the help of this unique group of lung cancer patients and their relatives, we can begin to understand why that might be the case," says Spitz.

The research team plans next to compare specific genes, such as those that help repair DNA damage, between the groups.


Story Source:

The above story is based on materials provided by University of Texas M. D. Anderson Cancer Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Texas M. D. Anderson Cancer Center. "Study Demonstrates That Lung Cancer Susceptibility Runs In Families." ScienceDaily. ScienceDaily, 3 April 2006. <www.sciencedaily.com/releases/2006/04/060402220421.htm>.
University of Texas M. D. Anderson Cancer Center. (2006, April 3). Study Demonstrates That Lung Cancer Susceptibility Runs In Families. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/04/060402220421.htm
University of Texas M. D. Anderson Cancer Center. "Study Demonstrates That Lung Cancer Susceptibility Runs In Families." ScienceDaily. www.sciencedaily.com/releases/2006/04/060402220421.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins